Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-11

Clinical Trial Update: The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the National Institute on Drug Abuse (NIDA) is evaluating whether a motivational enhancement intervention can reduce risk …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Adherence, HIV Risk Behaviors | Phase 2 | Status: UNKNOWN